Traditionally, in amyotrophic lateral sclerosis (ALS) and other motor neuron disorders, the diagnostic and research focus in the domain of magnetic resonance imaging (MRI) has been targeted on the brain and spinal cord. Nevertheless, structures outside the central nervous system (CNS) are core structures of the patholo...
Jan Kassubek, Hans-Peter Müller· Frontiers in Neurology· 1 citation
The differential diagnosis between degenerative cervical myelopathy (DCM) and early amyotrophic lateral sclerosis (ALS) is often clinically challenging; laboratory tests that support this distinction could be highly valuable. This study examined the concentrations of neurofilament light chain (NfL) and the phosphorylat...
Julia Goebell, F. Bachhuber, Jutta Karmann et al.· Journal of neural transmissi...· 0 citations
Cerebral small vessel disease (CSVD) is a leading cause of ischemic stroke and vascular cognitive impairment, yet currently lacks clinically established biomarkers for monitoring disease activity. While clinical routine magnetic resonance imaging (MRI) can provide quantitative measures of structural brain changes, it d...
L. Hasanova, P. Klassen, A. Nosanova et al.· Neurological Research and Pr...· 0 citations
The review is intended to summarize and discuss the increasing roles and perspectives of neuroimaging in the clinical and scientific work-up of amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MND). The applications of magnetic resonance imaging (MRI) and positron emission tomography (PET) identify...
Jan Kassubek, Hans-Peter Müller· Current Neurology and Neuros...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
